Rallybio Corp
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | |
| – | 15.8% | – | 11.4% | 2,755.9% | 78.9% | 2,700.5% | 2,865.1% | 1,954.2% | 1,646.4% | 1.4% | – | – | |
| – | -15.8% | – | 88.6% | -2,655.9% | 21.1% | -2,600.5% | -2,765.1% | -1,854.2% | -1,546.4% | 98.6% | – | – | |
| – | 6,968.4% | – | 4,318.4% | 2,755.9% | 19,355.3% | 2,700.5% | 2,865.1% | 1,954.2% | 1,646.4% | 32.1% | – | 1,335.0% | |
| – | 2,275.4% | – | 1,467.6% | 1,379.6% | 11,213.2% | 1,960.8% | 1,978.8% | 1,412.3% | 1,341.9% | 2,865.1% | – | 2,622.6% | |
| – | 9,243.9% | – | 5,786.0% | 1,379.6% | 30,568.4% | 1,960.8% | 1,978.8% | 1,412.3% | 1,341.9% | 2,331.1% | – | 2,564.7% | |
| – | -9,259.6% | – | -5,697.3% | -4,035.5% | -30,547.4% | -4,561.3% | -4,743.9% | -3,266.5% | -2,888.3% | -2,232.5% | – | -3,672.3% | |
| – | 727.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -8,878.1% | – | -5,430.1% | -3,834.8% | -29,063.2% | -4,452.4% | -4,576.9% | 7,554.7% | -2,636.0% | -3,904.7% | – | 7,256.2% | |
| – | 268.9% | – | 162.9% | – | -1,131.6% | – | 135.4% | – | – | – | – | – | |
| – | -8,878.1% | – | -5,430.1% | -3,834.8% | -29,063.2% | -4,452.4% | -4,576.9% | 7,554.7% | -2,636.0% | -3,904.7% | – | 7,051.2% | |
| – | -9,243.9% | – | -5,686.0% | -4,024.7% | -30,468.4% | -4,548.1% | -4,731.6% | -3,250.0% | -2,886.9% | -2,231.1% | – | 4,174.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.